• 产品
  • 供应商
  • CAS号
  • 采购
  • 资讯
  • 会展活动

您的位置:首页 >> 制药产品大全 >> 药品制剂 >> 心脑血管制剂 >> Reteplase ( rPA ) for Injection注射用瑞替普酶

Reteplase ( rPA ) for Injection注射用瑞替普酶

Reteplase ( rPA ) for Injection注射用瑞替普酶

详细描述
  • 主要销售市场:中/南美洲,东欧,亚洲,中东
  • 提供样品:
产品描述:

Reteplase ( rPA ) for Injection

[Dosage Form] Freeze-dried powder for injection.

[Indications]

Indicated for use in the management of acute myocardial infarction in adults for the improvement of ventricular function following AMI .

[Highlights]

Retaplase is the third generation thrombolytic drug, compared with Activase (Alteplase) from Boehringer Ingelheim GmbH, the second generation thrombolytic drug  

Retaplase has the advantages below:

• More convenient administration

• Less dosage

• Less adverse reaction

地址:

城市:

联系人:

电话:

传真:

成为供应商 在线获取商机 申请入驻
快速询盘
心脑血管类制剂
CPHI制药在线为您找到Reteplase ( rPA ) for Injection注射用瑞替普酶价格、Reteplase ( rPA ) for Injection注射用瑞替普酶详细参数、Reteplase ( rPA ) for Injection注射用瑞替普酶相关产品、Reteplase ( rPA ) for Injection注射用瑞替普酶供应商等信息,想了解当前Reteplase ( rPA ) for Injection注射用瑞替普酶最新报价,请联系深圳市迈高生物科技有限公司
CPHI 网上贸易平台: CPHI.cn| Pharmasources.com| CPHI-Online.com
客服热线:  86-400 610 1188 (周一至周五 9: 00-18: 00)